Migraine News

Though we all know why Justin Bieber is famous across the US but do we know the reason behind his popularity in India? This is an.. According to latest research, the risk of skin cancer is heightened by excessive use of sunscreen.

Migraine is a neurological, not vascular, disorder and both acute and preventive treatments being developed target peripheral and central nervous systems, according to a new study.

DoctorsHealthPress.com Reports on Study Showing New Herbal Remedy for Migraines The Doctors Health Press, a publisher of various natural health newsletters, books and reports, including the popular online Doctors Health Press e-Bulletin, is reporting on study that shows some herbal remedies and other natural cures may help stave off migraine ... (more)

Newswise - HONOLULU, May 17, 2012 -- The latest genetic and biological research shows that migraine is a neurological, not vascular, disorder and both acute and preventive treatments being developed target peripheral and central nervous systems, according to a prominent migraine expert addressing the American Pain Society , www.ampainsoc.org , ... (more)

In a randomized, double-blind trial, more adolescents with acute migraine became pain-free within two hours if they received a combination of sumatriptan and naproxen sodium instead of placebo.

TUESDAY May 15, 2012 -- A two-drug combination that relieves migraines in adults also works well in adolescents, new research indicates.

Treatment with sumatriptan and naproxen sodium is well tolerated and effective in reducing migraine pain in adolescents, according to a study published online May 14 in Pediatrics .

The guidelines, which were co-developed with the American Headache Society, were announced at the American Academy of Neurology's 64th Annual Meeting in and a Fellow of the American Academy of Neurology.

Bianca Varcellona has been suffering from migraine headaches since she was 12, but it wasn't until the past year that her condition became so debilitating that she sought a new treatment that included being hospitalized.

Migraine headaches are common, affecting nearly 28 million Americans, including 18 percent of women and 6 percent of men.

McDaniel said Tuesday that Abbot will pay Arkansas a total of $3.03 million as part of a $1.6 billion multi-state settlement.

Idaho will be getting nearly $2 million as part of two multi-state settlements with a pharmaceutical company accused of illegally marketing anti-psychotic drugs.

The attorney general's office has announced Arkansas will get $3.03 million for its part of two national lawsuits against Abbott Laboratories challenging off-label use of the drug Depakote.

Pozen, Inc. Announces Licensing Deal with Desitin Pharmaceuticals GmbH for MT 400 Migraine Treatment in 29 European Countries CHAPEL HILL, N.C.-- --POZEN Inc.

Chapel Hill drug company Pozen announced Tuesday that it has entered into a licensing agreement to development and commercialize MT 400, its experimental migraine drug, in Europe.

Many migraine sufferers could have fewer, less severe headaches if they took preventive medicines, but few eligible patients do, say doctors releasing updated treatment guidelines.

's stock had its "buy" rating restated by equities researchers at Ladenburg Thalmann in a report issued on Monday.

The N.C. Attorney General's Office said Monday that Abbott Laboratories will pay North Carolina about $3.5 million to resolve allegations that it improperly marketed the drug Depakote.

Utah will get $3.1 million from a settlement with Abbott Laboratories for marketing an anti-seizure drug for uses that were not FDA-approved. Utah is among 45 states receiving a portion of the $1.5 billion settlement, the nation's second largest with a pharmaceutical company.

Maryland is slated to receive $1.8 million for its part in a national settlement with Illinois-based Abbott Laboratories over allegations of illegal drug marketing, Attorney General Douglas F. Gansler said Monday.